|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E, Köhne CH, Hitre E, et al:
Cetuximab and chemotherapy as initial treatment for metastatic
colorectal cance. N Engl J Med. 360:1408–1417. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ham J, Babij C, Whitfield J, et al: A
c-Jun dominant negative mutant protects sympathetic neurons against
programmed cell death. Neuron. 14:927–939. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chatterjee A and Dutta CP: Alkaloids of
Piper longum Linn. I. Structure and synthesis of piperlongumine and
piperlonguminine. Tetrahedron. 23:1769–1781. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bezerra DP, Pessoa C, de Moraes MO,
Saker-Neto N, Silveira ER and Costa-Lotufo LV: Overview of the
therapeutic potential of piplartine (piperlongumine). Eur J Pharm
Sci. 48:453–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han SS, Son DJ, Yun H, Kamberos NL and
Janz S: Piperlongumine inhibits proliferation and survival of
Burkitt lymphoma in vitro. Leuk Res. 37:146–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu JM, Pan F, Li L, et al: Piperlongumine
selectively kills glioblastoma multiforme cells via reactive oxygen
species accumulation dependent JNK and p38 activation. Biochem
Biophys Res Commun. 437:87–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Raj L, Ide T, Gurkar AU, et al: Selective
killing of cancer cells by a small molecule targeting the stress
response to ROS. Nature. 475:231–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Randhawa H, Kibble K, Zeng H, Moyer MP and
Reindl KM: Activation of ERK signaling and induction of colon
cancer cell death by piperlongumine. Toxicol In Vitro.
27:1626–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bezerra DP, Militão GC, de Castro FO, et
al: Piplartine induces inhibition of leukemia cell proliferation
triggering both apoptosis and necrosis pathways. Toxicol In Vitro.
21:1–8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong EH, Kim YJ, Cho HJ, et al: Piplartine
induces caspase-mediated apoptosis in PC-3 human prostate cancer
cells. Oncol Rep. 20:785–792. 2008.PubMed/NCBI
|
|
12
|
Wang Y, Wang JW, Xiao X, et al:
Piperlongumine induces autophagy by targeting p38 signaling. Cell
Death Dis. 4:e8242013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shrivastava S, Kulkarni P, Thummuri D, et
al: Piperlongumine, an alkaloid causes inhibition of PI3K/Akt/mTOR
signaling axis to induce caspase-dependent apoptosis in human
triple-negative breast cancer cells. A Internat J Program Cell
Death. 19:1148–1164. 2014. View Article : Google Scholar
|
|
14
|
Adams DJ, Dai M, Pellegrino G, et al:
Synthesis, cellular evaluation, and mechanism of action of
piperlongumine analogs. Proc Natl Acad Sci USA. 109:15115–15120.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim TH, Song J, Kim SH, et al:
Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates
endoplasmic reticulum stress, and preferentially kills high-grade
glioma cells. Neuro Oncol. 16:1354–1364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction pathways activated by stress and inflammation:
a 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu R, Kim BR, Chen C, Hebbar V and Kong
AN: The roles of JNK and apoptotic signaling pathways in
PEITC-mediated responses in human HT-29 colon adenocarcinoma cells.
Carcinogenesis. 24:1361–1367. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu C, Shen G, Yuan X, et al: ERK and JNK
signaling pathways are involved in the regulation of activator
protein 1 and cell death elicited by three isothiocyanates in human
prostate cancer PC-3 cells. Carcinogenesis. 27:437–445. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang T, Arifoglu P, Ronai Z and Tew KD:
Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal
kinase (JNK1) signaling through interaction with the C terminus. J
Biol Chem. 276:20999–21003. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song M, Chen D, Lu B, et al: PTEN loss
increases PD-L1 protein expression and affects the correlation
between PD-L1 expression and clinical parameters in colorectal
cancer. PLoS One. 8:e658212013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bennett BL, Sasaki DT, Murray BW, et al:
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.
Proc Natl Acad Sci USA. 98:13681–13686. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fuchs SY, Dolan L, Davis RJ and Ronai Z:
Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun
N-kinase. Oncogene. 13:1531–1535. 1996.PubMed/NCBI
|
|
25
|
Musti AM, Treier M and Bohmann D: Reduced
ubiquitin-dependent degradation of c-Jun after phosphorylation by
MAP kinases. Science. 275:400–402. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jarvius M, Fryknäs M, D'Arcy P, Sun C,
Rickardson L, Gullbo J, Haglund C, Nygren P, Linder S and Larsson
R: Piperlongumine induces inhibition of the ubiquitin-proteasome
system in cancer cells. Biochem Biophys Res Commun. 431:117–123.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang N, Verna L, Hardy S, et al: c-Jun
triggers apoptosis in human vascular endothelial cells. Circ Res.
85:387–393. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Podar K, Raab MS, Tonon G, et al:
Up-regulation of c-Jun inhibits proliferation and induces apoptosis
via caspase-triggered c-Abl cleavage in human multiple myeloma.
Cancer Res. 67:1680–1688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bossy-Wetzel E: Bakiri L and Yaniv M:
Induction of apoptosis by the transcription factor c-Jun. EMBO J.
16:1695–1709. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Teraishi F, Wu S, Zhang L, et al:
Identification of a novel synthetic thiazolidin compound capable of
inducing c-Jun NH2-terminal kinase-dependent apoptosis in human
colon cancer cells. Cancer Res. 65:6380–6387. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kuntzen C, Sonuc N, De Toni EN, et al:
Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to
CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer
Res. 65:6780–6788. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Molton SA, Todd DE and Cook SJ: Selective
activation of the c-Jun N-terminal kinase (JNK) pathway fails to
elicit Bax activation or apoptosis unless the phosphoinositide
3-kinase (PI3K) pathway is inhibited. Oncogene. 22:4690–4701. 2003.
View Article : Google Scholar : PubMed/NCBI
|
